On ECHEMI
Home > Drugs > Changzhou Kangpu Pharmaceutical Co., Ltd.
Changzhou Kangpu Pharmaceutical Co., Ltd.
  • Founded in:

    1979-12-01
  • Country:

    China China
  • Address:

    No. 6, Jingde East Road, Qianhuang Town, Wujin District
  • Tax NO.:

    91320412250816627K
  • Registered Funds:

    20 million yuan
  • Website:

  • Email:

Related Drugs
Chlorpromazine hydrochloride
Name Description Content CAS NO. Registered Holders
Chlorpromazine hydrochloride

Extract from the above information

More

Extract from the above information

69-09-0 31
Methylthiouracil
Name Description Content CAS NO. Registered Holders
Methylthiouracil

Extract from the above information

More

Extract from the above information

56-04-2 2
Benzbromarone Tablets
The main ingredient of this product is benzbromarone. Chemical name: (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-3-benzofuranyl) ketone
Name Description Content CAS NO. Registered Holders
Benzbromarone

This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood.

More

This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood.

3562-84-3 8
Nifedipine Tablets
The main ingredient of this product is nifedipine. Chemical name: 2,6-dimethyl-4 (2-nitrophenyl)-1,,-dihydro-3,5-pyridinedicarboxylic acid dimethyl ester Molecular weight: C17H18N2O6
Name Description Content CAS NO. Registered Holders
Nifedipine

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

More

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

21829-25-4 75
Cimetidine tablets
Cimetidine. Its chemical name is: N-methyl-N"-[2[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-N-cyanoguanidine. Molecular formula: C10H16N6S Molecular weight: 252.34
Name Description Content CAS NO. Registered Holders
Cimetidine

It can significantly inhibit the basal gastric acid secretion during the day and night, and can also inhibit the gastric acid secretion induced by food, histamine, pentagastrin, caffeine and insulin.

More

It can significantly inhibit the basal gastric acid secretion during the day and night, and can also inhibit the gastric acid secretion induced by food, histamine, pentagastrin, caffeine and insulin.

51481-61-9 35
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.